1. Home
  2. MRSN vs OPHC Comparison

MRSN vs OPHC Comparison

Compare MRSN & OPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • OPHC
  • Stock Information
  • Founded
  • MRSN 2001
  • OPHC 2000
  • Country
  • MRSN United States
  • OPHC United States
  • Employees
  • MRSN N/A
  • OPHC N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • OPHC Major Banks
  • Sector
  • MRSN Health Care
  • OPHC Finance
  • Exchange
  • MRSN Nasdaq
  • OPHC Nasdaq
  • Market Cap
  • MRSN 47.1M
  • OPHC 48.3M
  • IPO Year
  • MRSN 2017
  • OPHC N/A
  • Fundamental
  • Price
  • MRSN $9.76
  • OPHC $4.02
  • Analyst Decision
  • MRSN Strong Buy
  • OPHC
  • Analyst Count
  • MRSN 3
  • OPHC 0
  • Target Price
  • MRSN $33.00
  • OPHC N/A
  • AVG Volume (30 Days)
  • MRSN 69.2K
  • OPHC 31.9K
  • Earning Date
  • MRSN 11-12-2025
  • OPHC 11-06-2025
  • Dividend Yield
  • MRSN N/A
  • OPHC N/A
  • EPS Growth
  • MRSN N/A
  • OPHC 6.01
  • EPS
  • MRSN N/A
  • OPHC 1.28
  • Revenue
  • MRSN $34,769,000.00
  • OPHC $41,269,000.00
  • Revenue This Year
  • MRSN N/A
  • OPHC N/A
  • Revenue Next Year
  • MRSN N/A
  • OPHC N/A
  • P/E Ratio
  • MRSN N/A
  • OPHC $3.17
  • Revenue Growth
  • MRSN 16.14
  • OPHC 36.79
  • 52 Week Low
  • MRSN $5.21
  • OPHC $3.53
  • 52 Week High
  • MRSN $70.75
  • OPHC $5.90
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 59.67
  • OPHC 41.86
  • Support Level
  • MRSN $8.76
  • OPHC $3.91
  • Resistance Level
  • MRSN $10.49
  • OPHC $4.02
  • Average True Range (ATR)
  • MRSN 0.84
  • OPHC 0.08
  • MACD
  • MRSN -0.06
  • OPHC -0.00
  • Stochastic Oscillator
  • MRSN 56.87
  • OPHC 26.05

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About OPHC OptimumBank Holdings Inc.

OptimumBank Holdings Inc serves as a bank holding company for OptimumBank. The Bank provides community banking services to individuals and corporate customers. Its services include demand interest-bearing and non-interest-bearing accounts, negotiable order of withdrawal accounts, money market deposit accounts, debit cards, and automated teller machines.

Share on Social Networks: